{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:45:12Z","timestamp":1790117112532,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,3]],"date-time":"2027-03-03T00:00:00Z","timestamp":1804032000000},"content-version":"am","delay-in-days":275,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-22-1-0598"],"award-info":[{"award-number":["W81XWH-22-1-0598"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.coi.2026.102747","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:58:43Z","timestamp":1772499523000},"page":"102747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Targeting synovial fibroblast KCa1.1 channels in rheumatoid arthritis"],"prefix":"10.1016","volume":"100","author":[{"given":"Robert","family":"Nicholas Elston","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2500-5874","authenticated-orcid":false,"given":"Christine","family":"Beeton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2026.102747_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/art.23177","article-title":"Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I","volume":"58","author":"Helmick","year":"2008","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102747_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2025.100330","article-title":"Epidemiological assessment of six major immune-mediated inflammatory diseases based on the Global Burden of Disease Study 2021: analyses of age-standardized incidence, prevalence, mortality, and disability-adjusted life years","volume":"11","author":"Huang","year":"2025","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.coi.2026.102747_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.689698","article-title":"Etiology and risk factors for rheumatoid arthritis: a state-of-the-art review","volume":"8","author":"Rom\u00e3o","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.coi.2026.102747_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10787-025-02073-6","article-title":"Molecular mechanisms and risk factors in rheumatoid arthritis: a comprehensive review","volume":"34","author":"Kumar","year":"2026","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.coi.2026.102747_bib5","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coi.2026.102747_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2025.100332","article-title":"Rheumatoid factor and anti-citrullinated protein IgA antibodies in the diagnosis, prognosis and monitoring of patients with rheumatoid arthritis","volume":"11","author":"Steffen","year":"2025","journal-title":"J Transl Autoimmun"},{"key":"10.1016\/j.coi.2026.102747_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res"},{"key":"10.1016\/j.coi.2026.102747_bib8","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nrrheum.2015.95","article-title":"Cartilage damage in osteoarthritis and rheumatoid arthritis\u00a0\u2013 two unequal siblings","volume":"11","author":"Pap","year":"2015","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.coi.2026.102747_bib9","first-page":"S179","article-title":"Methotrexate as the \u201canchor drug\u201d for the treatment of early rheumatoid arthritis","volume":"21","author":"Pincus","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2026.102747_bib10","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s10067-022-06454-y","article-title":"Effects of biologic and target synthetic disease-modifying anti-rheumatic drugs on sarcopenia in spondyloarthritis and rheumatoid arthritis: a systematic review and meta-analysis","volume":"42","author":"Ben Tekaya","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.coi.2026.102747_bib11","first-page":"658","article-title":"Effects of biologic disease-modifying anti-rheumatic drugs on the radiographic progression of rheumatoid arthritis: a systematic literature review","volume":"36","author":"Combe","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.coi.2026.102747_bib12","article-title":"Long-term outcomes in seronegative rheumatoid arthritis","volume":"12","author":"Kimbrough","year":"2025","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.coi.2026.102747_bib13","first-page":"S9","article-title":"Castrej\u00f3n I: update on methotrexate as the anchor drug for rheumatoid arthritis","volume":"71","author":"Pincus","year":"2013","journal-title":"Bull Hosp Jt Dis"},{"key":"10.1016\/j.coi.2026.102747_bib14","doi-asserted-by":"crossref","DOI":"10.1186\/ar2848","article-title":"ACR70-disease activity score remission achievement from switches between all the available biological agents in rheumatoid arthritis: a systematic review of the literature","volume":"11","author":"Alivernini","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2026.102747_bib15","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2026.102747_sbref16","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1136\/ard-2022-223396","article-title":"Cytokine-directed cellular cross-talk imprints synovial pathotypes in rheumatoid arthritis","volume":"82","author":"Kugler","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.coi.2026.102747_bib17","first-page":"20","article-title":"The role of the synovial fibroblast in rheumatoid arthritis: cartilage destruction and the regulation of matrix metalloproteinases","volume":"64","author":"Abeles","year":"2006","journal-title":"Bull NYU Hosp Jt Dis"},{"key":"10.1016\/j.coi.2026.102747_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-018-1783-9","article-title":"KCa1.1 and Kv1.3 channels regulate the interactions between fibroblast-like synoviocytes and T lymphocytes during rheumatoid arthritis","volume":"21","author":"Tanner","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2026.102747_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba4353","article-title":"Synoviocyte-targeted therapy synergizes with TNF inhibition in arthritis reversal","volume":"6","author":"Svensson","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.coi.2026.102747_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-02892-y","article-title":"Functionally distinct disease-associated fibroblast subsets in rheumatoid arthritis","volume":"9","author":"Mizoguchi","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2026.102747_bib21","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41586-019-1263-7","article-title":"Distinct fibroblast subsets drive inflammation and damage in arthritis","volume":"570","author":"Croft","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.coi.2026.102747_bib22","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-024-03343-4","article-title":"Targeting pathogenic fibroblast-like synoviocyte subsets in rheumatoid arthritis","volume":"26","author":"Qian","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2026.102747_bib23","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1074\/jbc.M111.312264","article-title":"KCa1.1 potassium channels regulate key proinflammatory and invasive properties of fibroblast-like synoviocytes in rheumatoid arthritis","volume":"287","author":"Hu","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102747_bib24","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1002\/art.38883","article-title":"KCa1.1 inhibition attenuates fibroblast-like synoviocyte invasiveness and ameliorates disease in rat models of rheumatoid arthritis","volume":"67","author":"Tanner","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.coi.2026.102747_bib25","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1096\/fj.201601097R","article-title":"KCa1.1 channels regulate \u03b21-integrin function and cell adhesion in rheumatoid arthritis fibroblast-like synoviocytes","volume":"31","author":"Tanner","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.coi.2026.102747_bib26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.clim.2015.04.001","article-title":"The cation channel Trpv2 is a new suppressor of arthritis severity, joint damage, and synovial fibroblast invasion","volume":"158","author":"Laragione","year":"2015","journal-title":"Clin Immunol"},{"key":"10.1016\/j.coi.2026.102747_sbref27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jphyss.2025.100013","article-title":"Calcium response via CRAC channels in human synovial cells induced by shear stress in rheumatoid arthritis","volume":"75","author":"Okumura","year":"2025","journal-title":"J Physiol Sci"},{"key":"10.1016\/j.coi.2026.102747_bib28","doi-asserted-by":"crossref","first-page":"C1082","DOI":"10.1152\/ajpcell.00204.2009","article-title":"An environmental sensor, TRPV4 is a novel regulator of intracellular Ca2+ in human synoviocytes","volume":"297","author":"Itoh","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.coi.2026.102747_bib29","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbrc.2007.05.178","article-title":"Expression of transient receptor potential vanilloid 1 (TRPV1) in synovial fibroblasts from patients with osteoarthritis and rheumatoid arthritis","volume":"359","author":"Engler","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coi.2026.102747_bib30","doi-asserted-by":"crossref","first-page":"36746","DOI":"10.1074\/jbc.M405621200","article-title":"Overactive bladder and incontinence in the absence of the BK large conductance Ca2+-activated K+ channel","volume":"279","author":"Meredith","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102747_bib31","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/01.CIR.0000156448.74296.FE","article-title":"Elevated blood pressure linked to primary hyperaldosteronism and impaired vasodilation in BK channel-deficient mice","volume":"112","author":"Sausbier","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.coi.2026.102747_bib32","doi-asserted-by":"crossref","first-page":"7917","DOI":"10.1073\/pnas.1205435109","article-title":"BK potassium channel modulation by leucine-rich repeat-containing proteins","volume":"109","author":"Yan","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2026.102747_bib33","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1113\/JP281952","article-title":"The LRRC family of BK channel regulatory subunits: potential roles in health and disease","volume":"600","author":"Gonzalez-Perez","year":"2022","journal-title":"J Physiol"},{"key":"10.1016\/j.coi.2026.102747_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-physiol-022516-034038","article-title":"Regulation of BK channels by beta and gamma subunits","volume":"81","author":"Gonzalez-Perez","year":"2019","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.coi.2026.102747_bib35","article-title":"Different expression of \u03b2 subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes","volume":"18","author":"Peth\u0151","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.coi.2026.102747_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2020.00226","article-title":"Pro-inflammatory cytokines drive deregulation of potassium channel expression in primary synovial fibroblasts","volume":"11","author":"Haidar","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.coi.2026.102747_bib37","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1074\/jbc.275.9.6453","article-title":"Cloning and functional characterization of novel large conductance calcium-activated potassium channel beta subunits, hKCNMB3 and hKCNMB4","volume":"275","author":"Brenner","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coi.2026.102747_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.117.245118","article-title":"Targeting KCa1.1 channels with a scorpion venom peptide for the therapy of rat models of rheumatoid arthritis","volume":"365","author":"Tanner","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coi.2026.102747_sbref39","doi-asserted-by":"crossref","DOI":"10.1186\/s12934-025-02800-2","article-title":"Limosilactobacillus reuteri enables oral-to-systemic absorption of iberiotoxin for treatment of collagen-induced arthritis in rats","volume":"24","author":"Kady","year":"2025","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.coi.2026.102747_sbref40","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-26196-w","article-title":"Mapping the functional expression of auxiliary subunits of KCa1.1 in glioblastoma","volume":"12","author":"Feher","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2026.102747_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98651-z","article-title":"TNF induces glycolytic shift in fibroblast like synoviocytes via GLUT1 and HIF1A","volume":"11","author":"Koedderitzsch","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.coi.2026.102747_bib42","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3390\/nu14112349","article-title":"Glucose as a potential key to fuel inflammation in rheumatoid arthritis","volume":"14","author":"Masuko","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.coi.2026.102747_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.750618","article-title":"Coronary large conductance Ca2+-activated K+ channel dysfunction in diabetes mellitus","volume":"12","author":"Lu","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.coi.2026.102747_bib44","doi-asserted-by":"crossref","DOI":"10.1038\/srep42240","article-title":"Relationship between auxiliary gamma subunits and mallotoxin on BK channel modulation","volume":"7","author":"Guan","year":"2017","journal-title":"Sci Rep"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791526000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:22:06Z","timestamp":1779510126000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791526000245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":44,"alternative-id":["S0952791526000245"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2026.102747","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting synovial fibroblast KCa1.1 channels in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2026.102747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102747"}}